JON Pty. Ltd.

 The Pharmaceuticals Division of JON Pty. Ltd. is Developing New  Metabolic Targeting Treatments using the Cancer cells own agressive  Metabolism to defeat  Cancers  . 

  In particular we are exploring the use of  a range of Pharmaceutical Metabolic  Inhibitors incorporated in novel delivery systems .  

 Laboratory trials on a range of Cancer cell types have been very successful. We are now moving into  patient trials.

The results of these trials will be made available to Patients and Oncologists as part of our continuing information updates

We would be pleased to provide more details of this exciting new technolgy by filling in the attached CONTACT  form